Posts
September 06 2016
Atossa Genetics Inc. announced the closing of their Underwritten offering in the amount of $2,875,000. EG&S acted as counsel to the Underwriter.
September 06 2016
Hemispherex Biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
August 26 2016
Northwest Biotherapeutics Inc. announced the closing of their PIPE offering in the amount of $1,280,000. EG&S acted as counsel to the Placement Agent.
August 26 2016
Optex Systems Holdings, Inc. announced the closing of their Underwritten offering in the amount of $4,751,945. EG&S acted as counsel to the Underwriter.
August 25 2016
Richard P. Kaye, a member of the Firm, was invited by the Dispute Resolution Section of The New York State Bar Association to participate in its continuing legal education program on Arbitration on October 28, 2016. Entitled The Next Iteration of ADR – It’s Not Just Alternative Anymore, Mr. Kaye will be a member of the panel for the topic “Building a Better Arbitration: Avoiding Pitfalls and Problems.” Mr. Kaye, who leads the firm’s Litigation Practice Group, has substantial experience in Alternative Dispute Resolution (ADR) proceedings, including both Arbitration and Mediation. The panel for this program, which consists of both practitioners and arbitrators, will share their experiences and suggestions for conducting an effective and successful arbitration hearing.
August 24 2016
EMAGIN Corp. announced the closing of their Registered Direct offering in the amount of $4,500,000. EG&S acted as counsel to the Placement Agent.
August 22 2016
Legend Oil and Gas, Ltd. announced the closing of their PIPE offering in the amount of $350,000. EG&S acted as counsel to the Investor.
August 19 2016
Stellar Acquisition III, a Greek blank check company, announced the closing of its initial public offering in the amount of $65,000,000. EG&S acted as counsel to Stellar.